Dr. Marcia Hogeling, MD

Dr. Hogeling practices at Santa Monica Surgicenter in Santa Monica, California.

Dr. Hogeling's NPI, 1871786293, was assigned on August 20, 2007. Dr. Hogeling graduated from University of British Columbia in 1999. Dr. Hogeling holds California license A86818.

Dr. Hogeling's primary practice is Santa Monica Surgicenter, at 2001 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5550.

Dr. Hogeling's primary practice is Santa Monica Surgicenter in Santa Monica, California. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Hogeling to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hogeling practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Hogeling's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Hogeling is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Hogeling's licenses on file in 2 states: California and Arizona.

Dmand AI lists skin discoloration among the conditions Dr. Hogeling treats.

CMS data shows 44 Medicare services from Dr. Hogeling across 1 procedure code in 2024, for 29 Medicare patients. Medicare paid $4,680 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Hogeling in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hogeling's median patient age at 14, with 52% women.

In 2023, Dr. Hogeling wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $165 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Hogeling for performance year 2024, reported as part of a group. Dr. Hogeling accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 49 papers to Dr. Hogeling, published from 2006 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Acne Vulgaris, Dermatologic Agents and Erythema. Dr. Hogeling has published most often in Pediatr Dermatol. Dr. Hogeling's most frequent co-authors are Ilona J. Frieden, MD, Carol Erin Cheng, MD and Megha M. Tollefson, MD.

CMS Open Payments shows 26 general payments to Dr. Hogeling from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 55% of the total. Pierre Fabre Pharmaceuticals, Inc. paid the most, $1,789.

Dr. Hogeling graduated from University of British Columbia in 1999. Dr. Hogeling is a member of AAD, International Society for the Study of Vascular Anomalies and Society for Pediatric Dermatology.

Dr. Hogeling is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.